Meng‐Feng Tsai

Tumor-Associated Macrophages: The Double-Edged Sword in Cancer Progression

Jeremy J.W. Chen, Yi‐Chen Lin, Pei‐Li Yao et al. · Journal of Clinical Oncology · 2004 · 373 citations · Full text

Medicine, Cancer Biology, Cell Biology +17

The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients

Shang‐Gin Wu, Yinan Liu, Meng‐Feng Tsai et al. · Oncotarget · 2016 · 236 citations · Full text

Medicine, Oncology, Pharmacology +17

Curcumin Inhibits Lung Cancer Cell Invasion and Metastasis through the Tumor Suppressor HLJ1

Huei‐Wen Chen, Jen‐Yi Lee, Jiying Huang et al. · Cancer Research · 2008 · 221 citations · Full text

Medicine, Oncology, Pharmacology +15

Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer

Jin‐Yuan Shih, Chien‐Hung Gow, Chong‐Jen Yu et al. · International Journal of Cancer · 2005 · 172 citations

Medicine, Oncology, Pathology +17

ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors

Cheng-Po Huang, Meng‐Feng Tsai, Tzu‐Hua Chang et al. · Cancer Letters · 2012 · 168 citations

Medicine, Cancer Biology, Oncology +12